Also in today’s newsletter: Ceuta migrant crossing and Uefa’s response to failed Fifa plan
Source link
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger | AstraZeneca
Britain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by…






